K101160 is an FDA 510(k) clearance for the ROCHE ORAL FLUID COCAINE. This device is classified as a Enzyme Immunoassay, Cocaine And Cocaine Metabolites (Class II - Special Controls, product code DIO).
Submitted by Roche Diagnostics (Indianapolis, US). The FDA issued a Cleared decision on February 11, 2011, 291 days after receiving the submission on April 26, 2010.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.3250.
| 510(k) Number | K101160 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | April 26, 2010 |
| Decision Date | February 11, 2011 |
| Days to Decision | 291 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | DIO — Enzyme Immunoassay, Cocaine And Cocaine Metabolites |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 862.3250 |